In patients with diabetes, myocardial fibrosis may contribute to the pathogenesis of heart
failure and arrhythmogenesis, increasing ventricular stiffness and delaying conduction …

Diabetes is a recognized risk factor for cardiovascular diseases and heart failure. Diabetic
cardiovascular dysfunction also underscores the development of diabetic retinopathy …

Diabetic cardiomyopathy is a major and severe cardiovascular complication of diabetes
mellitus. Ursolic acid, a pentacyclic triterpene compound widespread in fruits and plants …

Diabetic cardiomyopathy (DCM) is a prevalent cardiovascular complication of diabetes
mellitus, characterized by high morbidity and mortality rates worldwide. However, treatment …

Diabetic cardiomyopathy, characterized by the presence of diastolic and/or systolic
myocardial dysfunction, is one of the major causes of heart failure. Nobiletin, which is …

Abstract Background and Purpose Insulin therapies for Type 1 diabetes (T1D) have
limitations, such as glucose fluctuations, hypoglycaemia, and weight gain. Only pramlintide …

Diabetes-induced injury of myocardium, defined as diabetic cardiomyopathy (DCM),
accounts for significant mortality and morbidity in diabetic population. Alleviation of DCM by …

Diabetic cardiomyopathy is a major contributor to the increasing burden of heart failure
globally. Effective therapies remain elusive, in part due to the incomplete understanding of …

Background Diabetic patients, through incompletely understood mechanisms, endure
exacerbated ischemic heart injury compared to non-diabetic patients. Intermedin (IMD) is a …

Diabetic cardiomyopathy (DCM) develops independently of common cardiovascular co-
morbidities and is initiated by the metabolic derangements accompanying diabetes mellitus …